Haisco Pharmaceutical Group has entered a licensing and research collaboration with Eli Lilly to develop new medicines across various therapeutic…
Browsing: Haisco
China’s Haisco Pharmaceutical Group has entered a $2.9 billion licensing and research collaboration with Eli Lilly to develop innovative medicines…
China’s Haisco Pharmaceutical Group has entered into a significant licensing and research collaboration with Eli Lilly, valued at $2.9 billion,…
On May 29, 2026, Haisco Pharmaceutical Group announced a licensing and research collaboration with Eli Lilly to develop innovative medicines…